Europa Metals Ltd (LON:EUZ) shares surged in early deals on Friday after the group released a resource upgrade for the Toral lead-zinc-silver project located in northern Spain. The new independent resource estimate is for 3.8mln tonnes with a zinc equivalent grade (including lead credits) of 8.3% and silver at 30 grams per tonne. It marks a 40% increase in overall resource tonnes, including a 38% rise in contained, a 36% increase in lead and a 32% lift to silver volume. Toral now has a total resource of 17mln tonnes grading 6.9% zinc equivalent with 4.1% zinc, 2.9% lead, and 24 grams per tonne silver – representing 720,000 tonnes of zinc, 510,000 tonnes of lead, and 14mln ounces of silver.
Tower Resources PLC (LON:TRP) told investors it has held detailed talks over a loan facility that could cover work programmes ongoing at the Thali production-sharing contract in Cameroon. The company revealed that the proposed facility would provide up to US$10mln to the project operator for the NJOM-2 well, which is presently in progress. Subject to results, the financing facility could be expanded to support the next three production wells and a platform planned for the Njonji field, the company added.
Verona Pharma PLC (LON:VRP) is gearing up for a busy period with two clinical trials of its lead drug ensifentrine set to get underway before the end of the year. “Clinical data from prior studies of ensifentrine in other respiratory diseases have demonstrated ensifentrine improves lung function and reduces cellular markers of inflammation in the lungs,” the company said in an update on operational and financial results for the three months and six months to June 30, 2020. “We believe ensifentrine, with its novel mechanism of action, has the potential to improve oxygenation and lung function assisting recovery from COVID-19.” Financially, Verona is well set to achieve its plans. It ended the six months to June 30, 2020, with net cash of just over £18mln, a figure boosted in July with proceeds from a £159mln private placing.
ANGLE PLC (LON:AGL) has noted the results of new research from the Laboratory of Translational Oncology, School of Medicine, University of Crete, which demonstrated the potential of its Parsortix liquid biopsy system to assess whether non-small cell lung cancer (NSCLC) patients will respond to immunotherapy drugs. The AIM-listed firm said the study had combined an assessment of immunotherapy drugs known as PD-L1 immune checkpoint inhibitors, a novel treatment offered to patients with certain advanced cancers, with a second immune checkpoint, Indolamine-2,3-dioxygenase (IDO), on a patient’s circulating tumour cells (CTCs). ANGLE said the study demonstrated that the detection of IDO and CTCs, particularly of the IDO+/PD-L1- CTC subpopulation harvested using Parsortix, is significantly associated with reduced progression-free survival and overall survival in NSCLC patients treated with anti-PD-1 agents.
Westminster Group PLC (LON:WSG), the supplier of managed services and technology-based solutions, has revealed that it moved into profit in the first half of 2020. The group, which was operationally cash positive in the first half of the year, made a profit before tax of £236,000 versus a loss of £787,000 in the first half of last year, on revenues that rose by 24% to £6.96mln from £5.61mln. Underlying earnings (EBITDA) also turned positive, with EBITDA of £893,000, compared to a loss of £49,000 in the same period of last year. The coronavirus (COVID-19) pandemic has presented some challenges to the company but also some opportunities – e.g. fever screening at airports – and Westminster saw a significant increase in product sales worldwide, which more than offset reductions in other parts of the business.
Touchstone Exploration Inc (LON:TXP) revealed it has spudded the hotly anticipated Chinook-1 well, its latest exploration test within the Ortoire block, Trinidad as it posted as second-quarter operational update and financial results. The Chinook-1 well is targeting hydrocarbon prospects in the Herrera formation, the same horizon found in the successful Coho and Cascadura discoveries. It will be drilled to depth of 9,880 feet and the drill programme is expected to take 40 days.
Vietnam Holdings Ltd (LON:VNH) has continued to outperform the country’s local stock indices in the month of July, while the fund also revealed a strong grade of AA*A from its latest Principles of Responsible Investment (PRI) assessment, a UN-backed network of investors promoting sustainable investing. In its report for July, the fund reported a net asset value (NAV) of 173.3p per share, 2.1% lower month-on-month but better than the equivalent performance of the Vietnam All-Share Index which was down 3.6% in the same period. The company’s NAV is also at a 16% premium to its last closing price on Thursday of 149p.
Horizonte Minerals PLC (LON:HZM) has maintained a strong cash position as it moves towards the construction phase of the Araguaia nickel mine in Brazil, the group revealed as it reported half-year results. The miner said it had £15.6mln in the bank as at the end of June 2020 following the royalty arrangement with Orion Mining Finance signed at the end of 2019. The AIM-listed group announced yesterday that it had signed up five banks to lead the arrangement of a US$325mln finance package for the first phase at Araguaia.
Condor Gold PLC (LON:CDR) has revealed its objective remains to commence site preparation at its La India site in Nicaragua and place a deposit on a processing plant by the end of 2020, the miner said as it reported quarterly and half-year results. Condor currently has 1.12 million ounces (oz) of gold open pit mineral resources at La India permitted for extraction, inclusive of a mineral reserve of 675,000 oz gold. It is targeting production of 120,000 oz gold per annum from open-pit material for 7 years. Condor posted a loss of £355,000 in the half-year to June 30, 2020, reflecting the fact it is still in its development stage. Cash at the end of June was £7.5mln.
Integumen PLC (LON:SKIN) announced that it has received notification from multiple warrant holders to exercise warrants over 29,404,762 shares in the share capital of the company. This consists of 26,071,429 warrants with an exercise price of 2p and 3,333,333 warrants with an exercise price of 1.5p. The consideration for the exercise of the warrant shares amounts, in aggregate, to a cash value of £571,428.57. Gerard Brandon chief executive officer of Integumen commented: “The largest institutional shareholder, Helium Rising Stars Fund, who currently hold 7.3% of Integumen shares are exercising 60% of the above warrants which will increase their holding to 8.7%. We are grateful for their continued confidence in the future growth of the Company.”
Gfinity PLC (LON:GFIN), a leading esports and gaming solutions provider, announced that it has received warrant exercise notices over an aggregate of 10,000,000 new ordinary shares of 0.1 pence each in the capital of the company with an exercise price of 1p per share, providing the company with proceeds of £100,000.
Impax Environmental Markets PLC (LON:IEM) announced that at the company’s general meeting held on Friday, the resolutions in connection with the issue of further new ordinary shares on a non-pre-emptive basis, as set out in the circular sent to shareholders dated July 21, 2020, were approved by shareholders. It said details of the number of proxy votes cast for, against and withheld in respect of the resolutions (which were held on a poll) will be published on the company’s website: https://www.impaxenvironmentalmarkets.co.uk/
Supermarket Income REIT (LON:SUPR), the real estate investment trust providing secure, inflation-protected, long income from grocery property in the UK, has said it will announce its full-year results for the year ended June 30, 2020, on Thursday, September 17, 2020. A webcast for analysts and investors will be held at 8.30am on the day of the full-year results. To pre-register, investors can email: SUPR2020@atratocapital.com.